Lawrence Eichenfield is a Dermatology and Skin Diseases physician affiliated with University of California San Diego. OpenAlex indexes 790 publications with 30,212 citations (h-index 85); ClinicalTrials.gov lists 13 registered studies with this person as an investigator.
Data verified 7 Oct 2026
Overview
Updated 12 Oct 2026
Lawrence Eichenfield, MD, is affiliated with University of California San Diego. The public record shows 790 publications with 30,212 citations (h-index 85), centered on Dermatology and Skin Diseases, Asthma and respiratory diseases, Contact Dermatitis and Allergies. It also documents an investigator role on 13 registered clinical trials, industry payments reported by 42 companies.
- Most recent indexed publication: 2026 · The Journal of dermatological treatment
- Top research focus: Dermatology and Skin Diseases
- 13 registered trials on ClinicalTrials.gov
- Open Payments reporting from 42 companies
Generated from the cited public record · current as of 12 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 342.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 12 Oct 2026
Listed as an investigator on 13 registered studies on ClinicalTrials.gov. The most recent:
- Cantharidin Application in Molluscum Patients
Sponsor: Verrica Pharmaceuticals Inc.
- Cantharidin Application in Molluscum Patients-1
Sponsor: Verrica Pharmaceuticals Inc.
- BM Collection From NICU Infants for Composition
Sponsor: Kimberly-Clark Corporation
Industry payments
Updated 12 Oct 2026
42 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year202534 payments$126,577openpaymentsdata.cms.gov ↗
- PFIZER INC.Program year202528 payments$52,241openpaymentsdata.cms.gov ↗
- Incyte CorporationProgram year202554 payments$40,339openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 12 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.
The Journal of dermatological treatment
Article2026 - Update on Approved Therapies for Dystrophic and Junctional Epidermolysis Bullosa.
Pediatric dermatology
Review2026
Most-cited works
by citation count (OpenAlex)- 01
- 02Guidelines of care for the management of atopic dermatitisArticle1,285 citations2013
- 03Guidelines of care for the management of atopic dermatitisArticle1,230 citations2014
- 04Guidelines of care for the management of atopic dermatitisArticle887 citations2014
- 05
Network
Updated 12 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 12 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/lawrence-eichenfield-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/lawrence-eichenfield-10501750
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Lawrence-Eichenfield
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- Other
pedsderm.net/about/spd-members-in-the-news
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →pedsderm.net ↗ - X / Twitter
x.com/HCPLiveNews/status/1983551352581329027
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Weinreb, MD
University of California San Diego
Dilip Jeste, MD
University of California San Diego
Mark Ginsberg, MD
University of California San Diego
Christopher Girkin, MD
University of California San Diego
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania